2019 Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Innovation Enterprise Top 50 Emerging Enterprises
Classification:
Corporate News
Release time:
2019-10-16
Warmly celebrate Tiachen Medical's 2019 Top 50 New Enterprises in Biotechnology Innovation Enterprises in Guangdong-Hong Kong-Macao Greater Bay Area.
On October 16, 2019, the 2nd Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Innovation Enterprise Top 50 Award Ceremony and the Greater Bay Area Biotechnology Innovation and Development Summit, hosted by China Innovation Industry Research Institute and KPMG China and hosted by Guangdong Medical Valley, was held in Guangzhou. Grandly held. After nearly half a year of authoritative selection and evaluation, the three dimensions of technology, market and capital were investigated, taking into account the different development stages of enterprises, with technological innovation as the main indicator, Shenzhen Tiachen Medical was elected as the "2019 Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Innovation Enterprise 50" A strong leader".
The top 50 selection will focus on the selection of leading companies, pioneer companies, and emerging companies. The selection of companies includes medical device, biomedical technology and medical service companies. In the division of the list, an evaluation standard system including multiple primary and secondary indicators including technological development, market application, model innovation, team structure, and operational capability will be established for selection. The selection is not only to record the current status of the industry, but also to gain insight into the future development trend, focusing not only on the mature industry leaders, but also on the search for tomorrow's stars for the big health industry.
Global trends in the healthcare industry are clear, healthcare demand will continue to expand, demand for universal health coverage will continue to grow, consumers’ share of healthcare costs will continue to grow, healthcare innovation will accelerate, and technological developments will also enable healthcare Health care is more efficient.
As a high-tech enterprise, Tiachen Medical is synchronized with China's medical and health industry, promoting in-depth cooperation in the medical industry within the Guangdong-Hong Kong-Macao Greater Bay Area, and cooperating with the three places for the coordinated development, co-construction and sharing of health and wellness undertakings. Through continuous exploration, medical inspection systems such as cardiovascular and cerebrovascular, inflammation, and cancer screening are built on a small-scale fully automatic chemiluminescence platform with independent intellectual property rights, and a diversified product platform layout is created to promote the sustainable development of the industry ecology.
The medical and health industry in the Guangdong-Hong Kong-Macao Greater Bay Area is facing unprecedented development opportunities and vigorously promotes the development of the biotechnology industry. Tiachen Medical adheres to the concept of "development is the first priority, talent is the first resource, and innovation is the first driving force". Taking advantage of the unique resources and environment in Guangdong, Hong Kong and Macao, both in the construction of medical disciplines and in the cultivation of medical innovative talents, we should deepen cooperation with the energy resources of the three places, and join forces to provide better technology for China's health and health undertakings. Assure.
Attachment Download
Related News
2021-09-10
2021-06-30
2021-06-18
Follow Tiachen
Tel:
Add: 301, Block A, Building #1, Phase 2, Gaoxinqi Industrial Zone, 1st Liuxian Road, Bao’an District, Shenzhen
Add:3rd Floor, Building B, Youlitong Technology Park, No. 56 Qingsong Road, Pingshan District, Shenzhen